Killian Meara

Patients using the treatment reported reduced headache intensity and better quality of life.

Free medicine distribution was linked with a lower median total health care spending of $1641 per year over a 3-year period.

A majority of patients say that taking cannabis helps them with chronic pain management and other conditions.

A short supply of cisplatin and carboplatin is forcing health care providers to find less effective alternative treatments.

Active tobacco use and BMI were inversely related to the risk of developing IPD.

Exhaled carbon monoxide in vape users significantly decreased between their first and third clinical visits.

Some patients with PAH need to travel long distances, which may impact their access to quality care providers.

A higher dose of the carbonic anhydrase inhibitor does not seem to provide any additional improvements.

Balanced products showed greater improvements compared to either CBD-dominant or THC-dominant products.

A new meta-analysis found duloxetine to be the only commonly prescribed medication that was effective.

Insulet plans to commercialize the new product in the United States starting in 2024.